HIV/AIDS Clinical Trial
Official title:
ATN 157 -We Prevent: A Dyadic Approach to HIV Prevention and Care Among Young Male Couples
Verified date | May 2023 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
We Prevent seeks to develop and pilot test a developmentally-appropriate relationship skills session as an addition to the current Couples HIV Testing and Counseling (CHTC) intervention for young gay, bisexual and other men who have sex with men (YMSM). This project involves three phases to develop and pilot test the intervention. Phase I collected brief quantitative survey data, in-depth qualitative interview data, and cognitive interview data from YMSM and feedback from a technical expert group (TEG) to develop and refine the two-session intervention. Phase II involved conducting a one-arm pilot of the intervention condition to further refine the intervention content with a sample of 12 YMSM (6 dyads). Phase III involves conducting a randomized controlled trial (RCT) comparing the relationship-focused intervention to a control condition, which is HIV Testing, Counseling, and Referrals (CTR) alone with a sample of 320 YMSM.
Status | Completed |
Enrollment | 318 |
Est. completion date | August 20, 2021 |
Est. primary completion date | July 13, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 15 Years to 24 Years |
Eligibility | Inclusion Criteria: - Ages 15 to 24 years (inclusive) at time of screening - Current U.S. resident - Sufficient age for sexual consent in the current state of residence (assessed at both the individual and dyadic level) - Self-identify that they are in an emotional and sexual relationship with another male - Cisgender men (assigned male sex at birth and currently identifies as male) OR transgender men (assigned female at birth and identifies as male or transgender man - Self-reports that they engaged in any kind of sexual activity (oral, vaginal, anal) in their lifetime - Has access to computer/personal device/smart phone with internet access - Self-report being HIV negative or unknown serostatus - Speak and read English Exclusion Criteria: - Younger than age for consent without parental permission in the current state of residence - Assigned female sex at birth and currently identifies as something other than male or transgender man - Assigned male sex at birth but identifies as gender other than male or transgender man - Aged 14 years or younger or 25 or older at the time of screening - HIV-positive - Not currently in an emotional and/or sexual relationship with another male - Does not speak or read English - Reports intimate partner violence in the past 6 months |
Country | Name | City | State |
---|---|---|---|
United States | Center for Sexuality and Health Disparities | Ann Arbor | Michigan |
Lead Sponsor | Collaborator |
---|---|
University of Michigan | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of North Carolina, Chapel Hill |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sexual Risk Behavior | Anal or vaginal intercourse without condoms or PrEP that occurs with a person of known positive or unknown serostatus during follow-up period. | The number of participants who report sexual risk behavior at 3 months. | |
Primary | Sexual Risk Behavior | Anal or vaginal intercourse without condoms or PrEP that occurs with a person of known positive or unknown serostatus during follow-up period. | The number of participants who report sexual risk behavior at 6 months. | |
Primary | Sexual Risk Behavior | Anal or vaginal intercourse without condoms or PrEP that occurs with a person of known positive or unknown serostatus during follow-up period. | The number of participants who report sexual risk behavior at 9 months. | |
Secondary | HIV Communication | Participants completed the 9-item Couples Efficacy to Reduce HIV Threat scale .Participants responded to each item on 5-point Likert scale ranging from (1) strongly disagree to (5) strongly agree. The items were mean centered such that higher scores indicate that participants perceive that they can effectively communicate with their partner about HIV prevention strategies (range 1 to 5). | Mean at 3 months | |
Secondary | HIV Communication | Participants completed the 9-item Couples Efficacy to Reduce HIV Threat scale. Participants responded to each item on 5-point Likert scale ranging from (1) strongly disagree to (5) strongly agree. The items were mean centered such that higher scores indicate that participants perceive that they can effectively communicate with their partner about HIV prevention strategies (range 1 to 5). | Mean at 6 months | |
Secondary | HIV Communication | Participants completed the 9-item Couples Efficacy to Reduce HIV Threat scale. Participants responded to each item on 5-point Likert scale ranging from (1) strongly disagree to (5) strongly agree. The items were mean centered such that higher scores indicate that participants perceive that they can effectively communicate with their partner about HIV prevention strategies (range 1 to 5). | Mean at 9 months | |
Secondary | PrEP Use | Current PrEP use, which a self-report measure of whether the participant is currently using PrEP (yes/no). | The number of participants at 3 months | |
Secondary | PrEP Use | Current PrEP use, which a self-report measure of whether the participant is currently using PrEP (yes/no) | The number of participants at 6 months | |
Secondary | PrEP Use | Current PrEP use, which a self-report measure of whether the participant is currently using PrEP (yes/no) | The number of participants at 9 months | |
Secondary | HIV Testing | Self-reported HIV testing in the past 3 months | The number of participants at 3-months | |
Secondary | HIV Testing | Self-reported HIV testing in the past 3 months | The number of participants at 6 months | |
Secondary | HIV Testing | Self-reported HIV testing in the past 3 months | The number of participants at 9 months | |
Secondary | STI Testing | Any self-reported STI testing in the past 3 months | The number of participants at 3 months | |
Secondary | STI Testing | Any self-reported STI testing in the past 3 months | The number of participants at 6 months | |
Secondary | STI Testing | Any self-reported STI testing in the past 3 months | The number of participants at 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03215901 -
Life Plans Intervention Study
|
N/A | |
Completed |
NCT03289676 -
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
|
Phase 1 | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Active, not recruiting |
NCT04064567 -
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
|
N/A | |
Completed |
NCT04013295 -
Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya
|
N/A | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT03984136 -
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
|
N/A | |
Completed |
NCT02928900 -
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
|
N/A | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT02797262 -
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
|
N/A | |
Completed |
NCT02376582 -
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
|
Phase 1 | |
Completed |
NCT01957865 -
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
|
N/A | |
Completed |
NCT01616940 -
Minority AIDS Initiative Retention and Re-Engagement Project
|
N/A | |
Terminated |
NCT01443923 -
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
|
Phase 4 | |
Completed |
NCT01910714 -
Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
|
N/A | |
Completed |
NCT01084421 -
A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
|
N/A | |
Completed |
NCT01596322 -
International HIV Antiretroviral Adherence, Resistance and Survival
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Completed |
NCT03923231 -
Pharmacokinetics of Atazanavir in Special Populations
|